- GlobeNewswire•2 days agoEnzymotec Ltd. Granted New Patents for INFAT® in the U.S., Vayacog® in Japan and Phospholipid-Based Products in Canada and Korea
MIGDAL HA'EMEQ, Israel, Sept. 27, 2016-- Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that it has ...
- Zacks•last month
Enzymotec (ENZY) has witnessed a significant price decline in the past four weeks, and it has lately seen negative earnings estimate revisions as well.
Enzymotec Ltd. (ENZY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||6.80 x 600|
|Ask||6.85 x 500|
|Day's Range||6.72 - 7.06|
|52wk Range||6.60 - 10.32|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||36.05|
|Avg Vol (3m)||28,464|
|Dividend & Yield||N/A (N/A)|